Members

Blog Posts

gzbwlzdh

Posted by Diane on August 2, 2024 at 11:08pm 0 Comments

https://twitter.com/woods_otis98077/status/1819569582996443393 https://mcspartners.ning.com/photo/albums/bksricui https://etybuhodawax.storeinfo.jp/posts/54851468… Continue

pcbohduy

Posted by Thurman on August 2, 2024 at 11:06pm 0 Comments

https://ytexypyxesew.shopinfo.jp/posts/54851441 https://pastelink.net/irb6ye2c https://onkykanibygh.therestaurant.jp/posts/54851433 http://beterhbo.ning.com/profiles/blogs/sscbcjcg… Continue

iearwwqp

Posted by Helen on August 2, 2024 at 11:06pm 0 Comments

https://webhitlist.com/profiles/blogs/jyzdkhfe https://open.firstory.me/story/clzdjw0m00h1401w16im69i03 https://pastelink.net/cwhnph5p… Continue

ynctvkdy

Posted by Alma on August 2, 2024 at 11:01pm 0 Comments

https://ywogaknogepe.themedia.jp/posts/54851349 https://pastelink.net/zl7o0pbc https://open.firstory.me/story/clzdjjk48000r01xb77de6w6v… Continue

Top Content 

1 Specialist Removal Firm in Bangalore Will Make Sure of Painless Relocation

Specialist Removal Firm in Bangalore Will Make Sure of Painless Relocation
2 Most Beneficial Tips for Making Residential Shifting Easier

Most Beneficial Tips for Making Residential Shifting Easier
3 Support in School

Support in School
4 How to Combine SEO with Content Marketing

How to Combine SEO with Content Marketing
5 Time to Snap 8% off old school runescape cheap gold with code RSHFD8 from Rsorder for Gower Trailer& Father's day 6.18-6.20

Time to Snap 8% off old school runescape cheap gold with code RSHFD8 from Rsorder for Gower Trailer& Father's day 6.18-6.20

Jameshebrew's Blog (105)

Search Blog Posts

The liposome development and manufacturing services market is anticipated to grow at a CAGR of nearly 10% till 2035

Driven by the development of advanced methods for preparation and characterization of liposomes, and the application of these molecules in therapeutics and diagnostics, the demand for liposomes is expected to rise in the coming years.



London



Roots Analysis has announced the addition of “Liposome Manufacturing Market, 2022-2035” report to its list of offerings.



Despite the growing interest in liposome-based therapeutics and diagnostics, the development and… Continue

Added by jameshebrew on December 26, 2022 at 3:56am — No Comments

Medical Device Developers have been Compelled to Outsource their Manufacturing Operations to Contract Service Providers

The in-house development of peptide API requires necessary expertise and capabilities, including design, construction and maintenance of a facility which demands significant capital investments. Therefore, several small drug developers and, at times, certain pharma giants as well, have started outsourcing their manufacturing operations to contract service providers.



Over the years, the popularity of biologics has led to an evident shift in the focus of pharmaceutical companies, from… Continue

Added by jameshebrew on December 16, 2022 at 3:53am — No Comments

The single-use upstream bioprocessing technology market is projected to grow at a CAGR of 12%

Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufacturing equipment to single-use upstream bioprocessing systems.



Roots Analysis has announced the addition of “Single-use Upstream Bioprocessing Market, 2022-2035” report to its list of offerings.



The report features an extensive study on the extensive study of the current landscape and the likely future… Continue

Added by jameshebrew on December 15, 2022 at 12:25am — No Comments

The combination product services market is anticipated to grow at a CAGR of around 10%

Growing interest for combination products, coupled with the ongoing challenges of combining drug / biologic with a medical device, is anticipated to drive the demand for outsourcing combination products development and testing.



Roots Analysis has announced the addition of “Combination Product Services Market, 2022-2035” report to its list of offerings.



The development of drug-device combination products is a long-drawn-out process that not only requires novel technologies… Continue

Added by jameshebrew on December 14, 2022 at 12:22am — No Comments

The rare kidney disorders market is projected to grow at a CAGR of 17%

Considering the rising unmet need associated with rare kidney disorders and the growing adoption of available treatment options, industry stakeholders have made significant investments to enable the development of novel drug candidates targeting this set of rare diseases



London

Roots Analysis has announced the addition of the “Rare Kidney Disorders Market, 2022–2035” report to its list of offerings.



More than 90 candidates targeting rare kidney disorders are currently… Continue

Added by jameshebrew on December 12, 2022 at 1:10am — No Comments

The biosensors market focused on drug discovery and development is projected to grow at an annualized rate of 9%

In recent years, the use of biosensors in drug discovery has been on the rise, driven by several technological advancements and the growing demand for inexpensive and effective techniques for analyzing potential drug candidates.



Roots Analysis has announced the addition of “Biosensors Market: Focus on Drug Discovery and Drug Development, 2022 - 2035” report to its list of offerings.



A number of drug developers are already using novel biosensors for various drug discovery… Continue

Added by jameshebrew on December 8, 2022 at 11:06pm — No Comments

The at-home self-testing kits market is projected to grow at a healthy pace, till 2035

Driven by the various advantages offered by at-home self-testing kits and the growing awareness and adoption of such products post the onset of the COVID-19 outbreak, this market is abuzz with activity to develop kits for detection, diagnosis and screening purposes.



London

Roots Analysis has announced the addition of the “At home testing Kits Market , 2022–2035” report to its list of offerings.

Owing to several advantages offered by at-home self-testing kits for diagnostics… Continue

Added by jameshebrew on December 7, 2022 at 11:38pm — No Comments

The pharmaceutical industry is presently experiencing a prominent need for bioavailability enhancement technologies and services

Over the last couple of decades, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. It is considered to be one of the most important pharmacokinetic properties of a drug.



Bioavailability refers to the proportion of a drug that reaches systemic circulation unaltered, post dose administration. Additionally, it is a direct consequence of the absorption potential of an active pharmaceutical ingredient (API). The bioavailability of a drug is… Continue

Added by jameshebrew on December 6, 2022 at 11:10pm — No Comments

The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%

SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share



Roots Analysis has announced the addition of “SARM1 Inhibitors Therapeutics Market , 2022 – 2040” report to its list of offerings.



Presently, several industry and non-industry stakeholders are evaluating SARM1 inhibitors as potential… Continue

Added by jameshebrew on December 6, 2022 at 2:56am — No Comments

The cell and gene therapy CROs market is anticipated to grow at an annualized rate of 18%

Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years.



Roots Analysis has announced the addition of Cell and Gene Therapy CRO Market , 2022-2035” report to its list of offerings.



In order to mitigate the challenges associated with the cell and gene therapies research and development, around… Continue

Added by jameshebrew on December 5, 2022 at 2:43am — No Comments

The mRNA therapeutics and vaccines segment is anticipated to revolutionize the biopharmaceutical industry

Post the onset of the COVID-19 pandemic, mRNA therapeutics and vaccines have garnered significant attention as they have evolved as a revolutionary novel drug class for the treatment of COVID-19, as well as several other diseases, such as infectious diseases, oncological disorders, genetic disorders and other disorders.



mRNA therapeutics and vaccines have emerged as a promising alternative to conventional treatment approaches. During our research, we were able to identify more than… Continue

Added by jameshebrew on December 2, 2022 at 12:59am — No Comments

The Artificial Intelligence in Oncology market is anticipated to grow at a CAGR of 54%

The success of currently employed artificial intelligence (AI) solutions has encouraged researchers to explore the potential of such technologies in the healthcare sector, with its prime focus being oncology, to enable the treatment of several prevalent malignancies.



London



Roots Analysis has announced the addition of “Artificial Intelligence in Oncology Market, 2022-2035” report to its list of offerings.



Several AI technologies demonstrating the potential to… Continue

Added by jameshebrew on December 1, 2022 at 12:00am — No Comments

The viral vector, non-viral vector and gene therapy manufacturing market is projected to grow at a CAGR of ~15%

Rise in clinical research activity for genetically modified therapies has resulted in the increase in demand for vectors, offering lucrative opportunities to players having capabilities for in-house and contract manufacturing of various types of vectors.





Roots Analysis has announced the addition of “Viral Vector, Non-Viral Vector and Gene Therapy Manufacturing Market (5th Edition), 2022-2035” report to its list of offerings.



Over the past few years, cell and gene… Continue

Added by jameshebrew on November 30, 2022 at 1:09am — No Comments

Several Pharmaceutical Companies have Demonstrated a Preference to Outsource their Patient Recruitment Operations

Clinical trials form an essential part of the overall drug development process, evaluating the safety and efficacy of a drug candidate. Studies suggest that around 40% of the total investment made for the development of a drug candidate is dedicated to clinical trials.



However, the conduct of such trials is often fraught with challenges, including scientific and operational complexity, concerns associated with recruitment and retention of suitable patients, issues related to data… Continue

Added by jameshebrew on November 29, 2022 at 1:37am — No Comments

The ADC contract manufacturing market is projected to grow at a CAGR of more than 13%

Owing to the fact that a number of ADC developers are outsourcing various aspects of their business processes, CMOs engaged in this domain have undertaken several expansion initiatives to become one-stop-shops to cater to the diverse needs of ADC developers.



London



Roots Analysis has announced the addition of “ADC Contract Manufacturing Market (5th Edition), 2022-2035” report to its list of offerings.



In order to mitigate the challenges associated with Antibody… Continue

Added by jameshebrew on November 28, 2022 at 12:38am — No Comments

The taste masking market is anticipated to grow at a steady pace till 2035

Driven by the growing need to enhance palatability of oral drugs and drug adherence among pediatric and geriatric population, the demand for novel and advanced taste masking and taste assessment technologies is expected to rise in the coming years.



London



Roots Analysis has announced the addition of “Taste masking and Taste Assessment Services and Technologies Market, 2022-2035” report to its list of offerings.



The inherent expertise of CMOs and CDMOs in taste… Continue

Added by jameshebrew on November 25, 2022 at 5:32am — No Comments

CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

Amidst the active initiatives undertaken to develop more targeted anti-cancer therapies, CAR-T therapies have emerged as a promising option, given their ability to eradicate tumor cells from the body with minimal treatment-related side effects.



Further, CAR-T cell therapy, a relatively recent addition to the gamut of anticancer interventions, has demonstrated significant promise. Overall, this highly specific and promising form of CAR-T cell therapy treatment, which harnesses the… Continue

Added by jameshebrew on November 22, 2022 at 1:28am — No Comments

Manufacturing Execution System Providers in Healthcare Market

Every year, the healthcare industry generates a massive amount of data. In fact, the healthcare data currently constitutes around 30% share of the global data volume. Further, it is estimated that, by 2025, the data generated via the healthcare sector will rise at a compound annual growth rate of 36%.



It is important to consider that the constant management of such enormous volumes of data is a quite tedious process and challenging process. Specifically, management and handling of… Continue

Added by jameshebrew on November 21, 2022 at 2:07am — No Comments

The intricacies associated with cell therapy manufacturing have paved the way for novel automation technologies

Over the years, several advanced and innovative automation tools and technologies have been developed; these have been demonstrated to hold the potential for significant reduction in the cost associated with the manufacturing of advanced therapy medicinal products, thereby, making such products more affordable.



Considering the vast potential of cellular therapies in the treatment of rare disorders and sufficient body of evidence validating the clinical benefits / therapeutic… Continue

Added by jameshebrew on November 17, 2022 at 12:33am — No Comments

The companion diagnostics development services market, is anticipated to grow at a CAGR of over 10%

Given the various challenges associated with co-development of companion diagnostics and drug / therapy, drug developers prefer to rely on third-party service providers that offer customized services and advanced technologies.



Roots Analysis has announced the addition of “Companion Diagnostics Development Services Market (2nd Edition), 2022-2035” report to its list of offerings.



The growing pipeline of patient-centric targeted therapies has led to a surge in demand for… Continue

Added by jameshebrew on November 16, 2022 at 12:16am — No Comments

Latest Blog Posts

Most Popular Blog Posts

Monthly Archives

2023

2022

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service